lunedì 28 settembre 2020 - giovedì 8 ottobre 2020

The aim of the webinar is how to optimize treatments on patients with moderate mild ulcerative rectocolitis using the most
modern therapy strategies such as mesalazine or budesonide mmx.
A total of 9 cases will be presented by 9 different international key IBD experts
• Webinar mesalamine optimization in mild moderate UC
• Integration of budesonide mmx in algorithm of mild moderate UC optimization
• Monitoring mild moderate UC: a fundamental step of long term remission

per info segreteria@materia1a.it | +39 0363 1848776

Prof. Silvio Danese - Prof. Laurent Peyrin-Biroulet - Prof. Britta Siegmund